Insights

Innovative Microbial Solutions Solarea Bio develops plant-based microbial solutions targeting inflammatory health conditions, presenting an opportunity to partner with healthcare providers and supplement retailers seeking scientifically backed natural health products.

Growth & Funding Momentum Recent Series B financing of 15 million dollars from leading investors demonstrates strong market credibility and potential for expansion, making Solarea an appealing partner for corporate collaborations and strategic investments.

Focus on Inflammatory Health The company’s focus on addressing inflammatory processes such as postmenopausal bone loss and rheumatoid arthritis via microbiome-based therapies creates sales prospects with clinics, wellness centers, and pharmaceutical companies targeting these conditions.

Leadership & Market Presence With recent leadership appointments and active participation in industry events like the Future Food-Tech Summit, Solarea Bio is positioned to leverage influencer networks and industry platforms to accelerate product adoption and market penetration.

Product Launch & Consumer Engagement The beta launch of Bondia, a daily medical food for menopausal women, indicates an opportunity to collaborate with dietary supplement brands and caregiver organizations focused on women’s health and personalized nutrition markets.

sōlaria biō Tech Stack

sōlaria biō uses 8 technology products and services including WP Rocket, GoDaddy Website Builder, CookieYes, and more. Explore sōlaria biō's tech stack below.

  • WP Rocket
    Caching
  • GoDaddy Website Builder
    Content Management System
  • CookieYes
    Cookie Compliance
  • MySQL
    Database
  • cPanel
    Hosting Panels
  • jQuery
    Javascript Libraries
  • Vercel
    Platform As A Service
  • Apache HTTP Server
    Web Servers

Media & News

sōlaria biō's Email Address Formats

sōlaria biō uses at least 1 format(s):
sōlaria biō Email FormatsExamplePercentage
FLast@solareabio.comJDoe@solareabio.com
48%
First.Last@solareabio.comJohn.Doe@solareabio.com
2%
FLast@solareabio.comJDoe@solareabio.com
48%
First.Last@solareabio.comJohn.Doe@solareabio.com
2%

Frequently Asked Questions

What is sōlaria biō's official website and social media links?

Minus sign iconPlus sign icon
sōlaria biō's official website is solareabio.com and has social profiles on LinkedInCrunchbase.

What is sōlaria biō's SIC code NAICS code?

Minus sign iconPlus sign icon
sōlaria biō's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does sōlaria biō have currently?

Minus sign iconPlus sign icon
As of December 2025, sōlaria biō has approximately 11 employees across 1 continents, including North America. Key team members include Director, Discovery: A. B.Corporate Controller: G. H.Principal Computational Scientist: S. C.. Explore sōlaria biō's employee directory with LeadIQ.

What industry does sōlaria biō belong to?

Minus sign iconPlus sign icon
sōlaria biō operates in the Biotechnology Research industry.

What technology does sōlaria biō use?

Minus sign iconPlus sign icon
sōlaria biō's tech stack includes WP RocketGoDaddy Website BuilderCookieYesMySQLcPaneljQueryVercelApache HTTP Server.

What is sōlaria biō's email format?

Minus sign iconPlus sign icon
sōlaria biō's email format typically follows the pattern of FLast@solareabio.com. Find more sōlaria biō email formats with LeadIQ.

How much funding has sōlaria biō raised to date?

Minus sign iconPlus sign icon
As of December 2025, sōlaria biō has raised $1M in funding. The last funding round occurred on Sep 09, 2024 for $1M.

When was sōlaria biō founded?

Minus sign iconPlus sign icon
sōlaria biō was founded in 2017.

sōlaria biō

Biotechnology ResearchMassachusetts, United States11-50 Employees

Solarea Bio is a clinical-stage biotechnology company in Waltham, MA developing plant-based microbial solutions to some of the world’s largest health problems.  Solarea was founded in 2017 by a group of scientists and entrepreneurs eager to radically alter our understanding of the human microbiome and utilize its power to improve human health. The Solarea breakthrough came from the combined efforts of the company’s co-founders who established a link between the discovery of an untapped source of microorganisms with probiotic potential in healthy foods, and their applications in inflammatory processes including the gut-musculoskeletal axis. Using powerful genomic and bioinformatic tools, Solarea is mining its novel microbial strain collection to identify synergistic combinations of microbes and prebiotic plant fibers to develop solutions for patients suffering from inflammatory processes.

Section iconCompany Overview

SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2017
Employees
11-50

Section iconFunding & Financials

  • $1M

    sōlaria biō has raised a total of $1M of funding over 5 rounds. Their latest funding round was raised on Sep 09, 2024 in the amount of $1M.

  • $10M$25M

    sōlaria biō's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $1M

    sōlaria biō has raised a total of $1M of funding over 5 rounds. Their latest funding round was raised on Sep 09, 2024 in the amount of $1M.

  • $10M$25M

    sōlaria biō's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.